hydroxychloroquine has been researched along with Allergy, Drug in 12 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxychloroquine sulfate and other antimalarial drugs have been used successfully as adjunctive therapy for patients with cutaneous lesions of dermatomyositis over the past 20 years." | 7.71 | Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. ( Callen, JP; Pelle, MT, 2002) |
| "Hydroxychloroquine sulfate and other antimalarial drugs have been used successfully as adjunctive therapy for patients with cutaneous lesions of dermatomyositis over the past 20 years." | 3.71 | Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. ( Callen, JP; Pelle, MT, 2002) |
| "Hydroxychloroquine (HCQ) is an antimalarial agent with immunomodulatory effects." | 1.33 | Desensitization to hydroxychloroquine--experience of 4 patients. ( Breuer, GS; Mates, M; Navon, P; Nesher, G; Zevin, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Takamasu, E | 1 |
| Yokogawa, N | 1 |
| Shimada, K | 1 |
| Sugii, S | 1 |
| Rowane, M | 1 |
| Schend, J | 1 |
| Patel, J | 1 |
| Hostoffer, R | 1 |
| Barailler, H | 1 |
| Milpied, B | 1 |
| Chauvel, A | 1 |
| Claraz, P | 1 |
| Taïeb, A | 1 |
| Seneschal, J | 1 |
| Darrigade, AS | 1 |
| Pérez-Sánchez, N | 1 |
| Esponda-Juárez, K | 1 |
| Cimarra Álvarez, M | 1 |
| Aleo Luján, E | 1 |
| Toledano Martínez, E | 1 |
| Fernandez-Rivas, MM | 1 |
| Alniemi, DT | 1 |
| Gutierrez, A | 1 |
| Drage, LA | 1 |
| Wetter, DA | 1 |
| Caramaschi, P | 1 |
| Barbazza, R | 1 |
| Tinazzi, I | 1 |
| Biasi, D | 1 |
| Pelle, MT | 1 |
| Callen, JP | 1 |
| NIEWEG, HO | 1 |
| BOUMA, HG | 1 |
| DEVRIES, K | 1 |
| JANSZ, A | 1 |
| MCDUFFIE, FC | 1 |
| Mates, M | 1 |
| Zevin, S | 1 |
| Breuer, GS | 1 |
| Navon, P | 1 |
| Nesher, G | 1 |
| Sontheimer, RD | 1 |
| Getz, MA | 1 |
| Subramanian, R | 1 |
| Logemann, T | 1 |
| Ballantyne, F | 1 |
12 other studies available for hydroxychloroquine and Allergy, Drug
| Article | Year |
|---|---|
Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Clinical Protocols; Cyclophosphamide; Dose-Respo | 2019 |
Rapid desensitization of hydroxychloroquine.
Topics: Anti-Inflammatory Agents; Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Hydro | 2020 |
Delayed hypersensitivity skin reaction to hydroxychloroquine: Successful short desensitization.
Topics: Aged, 80 and over; Antiphospholipid Syndrome; Clinical Protocols; Desensitization, Immunologic; Drug | 2019 |
Short desensitization in an adolescent with hydroxychloroquine anaphylaxis.
Topics: Adolescent; Allergens; Anaphylaxis; Clinical Protocols; Desensitization, Immunologic; Drug Hypersens | 2014 |
Subacute Cutaneous Lupus Erythematosus: Clinical Characteristics, Disease Associations, Treatments, and Outcomes in a Series of 90 Patients at Mayo Clinic, 1996-2011.
Topics: Antirheumatic Agents; Drug Hypersensitivity; Female; Humans; Hydroxychloroquine; Lupus Erythematosus | 2017 |
Desensitization to hydroxychloroquine: 4 cases.
Topics: Antirheumatic Agents; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Female; H | 2011 |
Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Case-Control Studies; Chemotherapy, Ad | 2002 |
HAEMATOLOGICAL SIDE-EFFECTS OF SOME ANTI-RHEUMATIC DRUGS.
Topics: Aminopyrine; Antirheumatic Agents; Aspirin; Blood Platelets; Chloroquine; Colchicine; Complement Fix | 1963 |
BONE MARROW DEPRESSION AFTER DRUG THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Topics: Adolescent; Agranulocytosis; Anemia; Anemia, Aplastic; Anti-Bacterial Agents; Bone Marrow; Bone Marr | 1965 |
Desensitization to hydroxychloroquine--experience of 4 patients.
Topics: Adult; Antirheumatic Agents; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Dr | 2006 |
Desensitization to hydroxychloroquine: alternative interpretations.
Topics: Antirheumatic Agents; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Drug Tole | 2007 |
Acute necrotizing eosinophilic myocarditis as a manifestation of severe hypersensitivity myocarditis. Antemortem diagnosis and successful treatment.
Topics: Adult; Amitriptyline; Cardiomyopathy, Dilated; Drug Hypersensitivity; Eosinophilia; Female; Humans; | 1991 |